Suppr超能文献

改进淋病奈瑟菌拓扑异构酶 A 基因型的测定方法可用于临床标本。

Improved determination of Neisseria gonorrhoeae gyrase A genotype results in clinical specimens.

机构信息

Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.

Department of Medicine, Boston Children's Hospital, Boston, MA, USA.

出版信息

J Antimicrob Chemother. 2019 Oct 1;74(10):2913-2915. doi: 10.1093/jac/dkz292.

Abstract

BACKGROUND

The emergence of drug-resistant Neisseria gonorrhoeae has prompted the development of rapid molecular assays designed to determine antimicrobial susceptibility. One common assay uses high-resolution melt analysis to target codon 91 of the gyrase A gene (gyrA) to predict N. gonorrhoeae susceptibility to ciprofloxacin.

METHODS

We extracted DNA from remnant clinical specimens that had previously tested positive for N. gonorrhoeae using the Aptima Combo 2 for CT/NG assay (Hologic, San Diego, CA, USA). We selected DNA extracts from specimens with indeterminate, WT and mutant gyrA genotype results from a previous study using high-resolution melt analysis to detect the gyrA codon 91 mutation. We re-tested those specimens using the recently CE-marked ResistancePlus GC (beta) assay (SpeeDx, Sydney, Australia).

RESULTS

Of 86 specimens with indeterminate gyrA genotypes on high-resolution melt analysis, the ResistancePlus GC (beta) assay (SpeeDx) identified 30 (35%) WT, 22 (26%) mutant and 34 (40%) indeterminate gyrA genotypes.

CONCLUSIONS

The ResistancePlus GC (beta) assay showed improved N. gonorrhoeae gyrA genotype determination compared with a prior gyrA genotypic high-resolution melt assay.

摘要

背景

耐抗生素淋病奈瑟菌的出现促使人们开发了旨在确定抗菌药物敏感性的快速分子检测方法。一种常见的检测方法使用高分辨率熔解分析来靶向拓扑异构酶 A 基因(gyrA)的密码子 91,以预测淋病奈瑟菌对环丙沙星的敏感性。

方法

我们从先前使用 Aptima Combo 2 用于 CT/NG 检测(美国圣地亚哥 Hologic)检测为淋病奈瑟菌阳性的剩余临床标本中提取 DNA。我们从先前使用高分辨率熔解分析检测 gyrA 密码子 91 突变的研究中选择了 gyrA 基因型结果为不确定、WT 和突变的 DNA 提取物。我们使用最近获得 CE 标记的 ResistancePlus GC(beta)检测(澳大利亚悉尼 SpeeDx)重新检测了这些标本。

结果

在高分辨率熔解分析中,86 份 gyrA 基因型不确定的标本中,ResistancePlus GC(beta)检测(SpeeDx)鉴定出 30 份(35%)WT、22 份(26%)突变和 34 份(40%)不确定的 gyrA 基因型。

结论

与之前的 gyrA 基因分型高分辨率熔解分析相比,ResistancePlus GC(beta)检测在淋病奈瑟菌 gyrA 基因型确定方面显示出了更好的效果。

相似文献

1
Improved determination of Neisseria gonorrhoeae gyrase A genotype results in clinical specimens.
J Antimicrob Chemother. 2019 Oct 1;74(10):2913-2915. doi: 10.1093/jac/dkz292.
3
A multisite implementation of a real-time polymerase chain reaction assay to predict ciprofloxacin susceptibility in Neisseria gonorrhoeae.
Diagn Microbiol Infect Dis. 2019 Jul;94(3):213-217. doi: 10.1016/j.diagmicrobio.2018.12.018. Epub 2019 Jan 14.
9
Evaluation of the molecular detection of ciprofloxacin resistance in Neisseria gonorrhoeae by the ResistancePlus GC assay (SpeeDx).
Diagn Microbiol Infect Dis. 2021 Apr;99(4):115262. doi: 10.1016/j.diagmicrobio.2020.115262. Epub 2020 Nov 12.
10
Determination of Neisseria gonorrhoeae susceptibility to ciprofloxacin in clinical specimens from men using a real-time PCR assay.
Int J Antimicrob Agents. 2013 Jul;42(1):63-7. doi: 10.1016/j.ijantimicag.2013.02.026. Epub 2013 Apr 24.

本文引用的文献

4
Superior Multiplexing Capacity of PlexPrimers Enables Sensitive and Specific Detection of SNPs and Clustered Mutations in qPCR.
PLoS One. 2017 Jan 23;12(1):e0170087. doi: 10.1371/journal.pone.0170087. eCollection 2017.
8
Molecular tests for the detection of antimicrobial resistant Neisseria gonorrhoeae: when, where, and how to use?
Curr Opin Infect Dis. 2016 Feb;29(1):45-51. doi: 10.1097/QCO.0000000000000230.
9
Stemming the tide of drug-resistant Neisseria gonorrhoeae: the need for an individualized approach to treatment.
J Antimicrob Chemother. 2015 Feb;70(2):374-81. doi: 10.1093/jac/dku396. Epub 2014 Oct 19.
10
Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada.
JAMA. 2013 Jan 9;309(2):163-70. doi: 10.1001/jama.2012.176575.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验